Adaptimmune Therapeutics plc (473A) — Net Asset Momentum
Adaptimmune Therapeutics plc (473A) recorded a net asset momentum of -70.0% as of December 2024, with net assets of €11.85 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 473A days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Adaptimmune Therapeutics plc Net Asset Momentum (2016–2024)
This chart tracks Adaptimmune Therapeutics plc's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is -70.0%, with net assets of €11.85 Million EUR as of December 2024. Read how much debt does Adaptimmune Therapeutics plc carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for Adaptimmune Therapeutics plc (2016–2024)
The table below shows the complete annual net asset history for Adaptimmune Therapeutics plc from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Adaptimmune Therapeutics plc market cap and net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €11.85 Million | €245.96 Million | €234.11 Million | ▼ -70.0% |
| 2023 | €39.51 Million | €282.62 Million | €243.10 Million | ▼ -51.7% |
| 2022 | €81.88 Million | €328.92 Million | €247.04 Million | ▼ -60.2% |
| 2021 | €205.96 Million | €469.55 Million | €263.58 Million | ▼ -39.6% |
| 2020 | €341.23 Million | €451.14 Million | €109.92 Million | ▲ +176.0% |
| 2019 | €123.64 Million | €181.54 Million | €57.91 Million | ▼ -49.9% |
| 2018 | €246.88 Million | €276.74 Million | €29.85 Million | ▲ +21.6% |
| 2017 | €202.98 Million | €281.15 Million | €78.16 Million | ▲ +22.2% |
| 2016 | €166.14 Million | €234.51 Million | €68.37 Million | — |